Managing medical devices within a regulatory framework
Saved in:
Other Authors: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Amsterdam :
Elsevier,
2016, ©2017.
|
Subjects: | |
ISBN: | 9780128041925 0128041927 9780128041796 012804179X |
Physical Description: | 1 online resource (382) |
LEADER | 04624cam a2200397 a 4500 | ||
---|---|---|---|
001 | kn-ocn958455787 | ||
003 | OCoLC | ||
005 | 20240717213016.0 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 160916t20162016ne o 001 0 eng d | ||
040 | |a IDEBK |b eng |e pn |c IDEBK |d YDX |d EBLCP |d OPELS |d OCLCQ |d IDEBK |d QCL |d KNOVL |d OCLCQ |d N$T |d STF |d OCLCQ |d ERL |d OCLCQ |d U3W |d MERUC |d D6H |d OCLCQ |d CEF |d RRP |d OCLCQ |d S2H |d OCLCO |d OCLCQ |d OCLCL |d SXB | ||
020 | |a 9780128041925 |q (electronic bk.) | ||
020 | |a 0128041927 |q (electronic bk.) | ||
020 | |z 9780128041796 | ||
020 | |z 012804179X | ||
035 | |a (OCoLC)958455787 |z (OCoLC)958449498 |z (OCoLC)958779001 | ||
245 | 0 | 0 | |a Managing medical devices within a regulatory framework / |c edited by Beth Ann Fielder. |
260 | |a Amsterdam : |b Elsevier, |c 2016, ©2017. | ||
300 | |a 1 online resource (382) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
505 | 0 | |a Front Cover; Managing Medical Devices within a Regulatory Framework; Related titles; Managing Medical Devices within a Regulatory Framework; Copyright; Dedication; Contents; List of Contributors; Foreword; Preface; 1 -- Medical Device Development and Regulatory Overview; 1 -- Reframing Product Life Cycle for Medical Devices; 1.1 INTRODUCTION; 1.2 FDA TOTAL PRODUCT LIFE CYCLE; 1.2.1 CONCEPTION; 1.2.2 PROTOTYPE; 1.2.3 PRECLINICAL INVESTIGATION; 1.2.4 ADVANCED CLINICAL/POSTMARKETING STUDIES; 1.2.5 END OF LIFE; 1.3 EUROPEAN COMMISSION PRODUCT LIFE CYCLE; 1.4 SUMMARY; DEFINITIONS; REFERENCES. | |
505 | 8 | |a RECOMMENDATIONS FOR ADDITIONAL READING2 -- Overview of Medical Device Clinical Trials; 2.1 INTRODUCTION; 2.2 MEDICAL DEVICE SUBMISSIONS OVERVIEW; 2.3 MEDICAL DEVICE CLINICAL TRIALS; 2.3.1 INVESTIGATIONAL DEVICE EXEMPTION; 2.3.2 CLINICAL TRIALS; 2.3.3 MANUFACTURING AND ADDITIONAL STANDARDS; 2.4 REGULATORY PROFILE OF THE US MEDICAL DEVICE BY CLASSIFICATION TYPE; 2.4.1 CLASS I MEDICAL DEVICES; 2.4.2 CLASS II MEDICAL DEVICES; 2.4.3 CLASS III MEDICAL DEVICES; 2.5 REGULATORY PROFILE OF THE EU MEDICAL DEVICE BY CLASSIFICATION TYPE; 2.6 SUMMARY; DEFINITIONS; REFERENCES. | |
505 | 8 | |a RECOMMENDATIONS FOR ADDITIONAL READING3 -- Review Regulatory Guidelines by Device Classification Type; 3.1 INTRODUCTION; 3.2 BASIC OVERVIEW OF THE PREMARKET NOTIFICATION 510(K); 3.2.1 TYPES OF 510(K); 3.2.2 PRIMARY 510(K) SUBMISSION STEPS; 3.2.3 SUBSTANTIAL EQUIVALENCE; 3.3 PREMARKET APPROVAL APPLICATION REGULATORY PATH; 3.3.1 PMA TYPES; 3.3.2 PRESUBMISSION INTERACTION; 3.3.3 PMA FOOD AND DRUG ADMINISTRATION REVIEWS; 3.3.4 PRE-INVESTIGATIONAL DEVICE EXEMPTION SUBMISSION; 3.4 Medical Device Class I; 3.5 MEDICAL DEVICE CLASS II; 3.6 MEDICAL DEVICE CLASS III. | |
505 | 8 | |a 3.6.1 CLINICAL EVALUATION AND IDE SUBMISSION3.7 SUMMARY; DEFINITIONS; REFERENCES; RECOMMENDATIONS FOR ADDITIONAL READING; 4 -- Manufacturing/Distribution Considerations; 4.1 INTRODUCTION; 4.2 US PRECLINICAL STAGE; 4.2.1 PRODUCT LIFE CYCLE MANAGEMENT; 4.2.2 CURRENT GOOD MANUFACTURING PRACTICES; 4.3 US POSTMARKET STAGE; 4.3.1 ADVERSE EVENT MEDICAL DEVICE REPORTING; 4.3.2 POSTMARKETING 522 STUDIES; 4.3.3 REIMBURSEMENT; 4.4 EUROPEAN UNION CE MARKING: PREMARKETING STAGE; 4.4.1 CE MARKING; 4.4.2 NOTIFIED BODY BEST PRACTICES; 4.5 EU POSTMARKET STAGE; 4.5.1 ADVERSE EVENT MEDICAL DEVICE REPORTING. | |
505 | 8 | |a 4.5.2 POSTMARKETING STUDIES4.5.3 REIMBURSEMENT; 4.6 SUMMARY; DEFINITIONS; REFERENCES; RECOMMENDATIONS FOR ADDITIONAL READING; 2 -- Defining and Meeting Regulatory Challenges in Clinical Engineering; 5 -- Defining and Meeting Regulatory Challenges in Clinical Engineering; 5.1 INTRODUCTION; 5.2 BIOCOMPATIBILITY; 5.2.1 ISO AND OTHER RESOURCE GUIDANCE; 5.2.2 CROSS-FUNCTIONAL KNOWLEDGE BASE REPOSITORIES; 5.2.2.1 The Front End of Medical Device Development in the Product Life Cycle; 5.2.2.2 The Back End of Medical Device Development in the Product Life Cycle. | |
506 | |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty | ||
590 | |a Knovel |b Knovel (All titles) | ||
650 | 0 | |a Medical instruments and apparatus |x Management. | |
655 | 7 | |a elektronické knihy |7 fd186907 |2 czenas | |
655 | 9 | |a electronic books |2 eczenas | |
700 | 1 | |a Fiedler, Beth Ann. | |
776 | 0 | 8 | |i Print version: |t Managing medical devices within a regulatory framework. |d Amsterdam : Elsevier, 2016, ©2017 |z 012804179X |z 9780128041796 |w (OCoLC)949750139 |
856 | 4 | 0 | |u https://proxy.k.utb.cz/login?url=https://app.knovel.com/hotlink/toc/id:kpMMDRF003/managing-medical-devices?kpromoter=marc |y Full text |